"G.M. Lancisi" Cardiovascular Center, 60126 Ancona, Italy.
Department of Biomedical Sciences and Public Health, Marche Polytechnic University, 60121 Ancona, Italy.
Medicina (Kaunas). 2024 Jul 1;60(7):1082. doi: 10.3390/medicina60071082.
Mitral regurgitation (MR) is a broadly diffuse valvular heart disease (VHD) with a significant impact on the healthcare system and patient prognosis. Transcatheter mitral valve interventions (TMVI) are now well-established techniques included in the therapeutic armamentarium for managing patients with mitral regurgitation, either primary or functional MR. Even if the guidelines give indications regarding the correct management of this VHD, the wide heterogeneity of patients' clinical backgrounds and valvular and heart anatomies make each patient a unique case, in which the appropriate device's selection requires a multimodal imaging evaluation and a multidisciplinary discussion. Proper pre-procedural evaluation plays a pivotal role in judging the feasibility of TMVI, while a cooperative work between imagers and interventionalist is also crucial for procedural success. This manuscript aims to provide an exhaustive overview of the main parameters that need to be evaluated for appropriate device selection, pre-procedural planning, intra-procedural guidance and post-operative assessment in the setting of TMVI. In addition, it tries to give some insights about future perspectives for structural cardiovascular imaging.
二尖瓣反流（MR）是一种广泛弥漫性的瓣膜性心脏病（VHD），对医疗系统和患者预后有重大影响。经导管二尖瓣瓣膜介入（TMVI）现在是一种成熟的技术，被纳入治疗二尖瓣反流患者的治疗手段，包括原发性或功能性 MR。尽管指南给出了关于这种 VHD 正确管理的建议，但患者临床背景和瓣膜及心脏解剖结构的广泛异质性使得每位患者都是一个独特的病例，在这种情况下，需要进行多模态影像学评估和多学科讨论来选择合适的器械。适当的术前评估在判断 TMVI 的可行性方面起着关键作用，而影像科医生和介入医生之间的合作对于手术的成功也至关重要。本文旨在全面概述 TMVI 中合适器械选择、术前规划、术中指导和术后评估所需评估的主要参数。此外，它还试图对结构性心血管成像的未来前景提供一些见解。
